The largest analysis to date of patients taking GLP-1 receptor agonists (GLP-1RAs) has investigated their effects on nearly 175 diseases, and found that compared to three other classes of diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback